Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FTSE 100 pulled down by miners, glum retail sales data

08/25/2020 | 03:57am EDT

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

* UK retailers cut jobs by most since 2009 - CBI

* Tech firm Aveva jumps on signing $5 bln takeover deal

* AstraZeneca rises on launching COVID-19 treatment trial

* FTSE 100 down 1.1%, FTSE 250 down 0.6%

Aug 25 (Reuters) - The export-laden FTSE 100 index closed lower on Tuesday, weighed down by miners and a stronger pound, while an unexpected drop in retail sales kept risk sentiment at bay.

The blue-chip London index fell 1.1% and the mid-cap FTSE 250 dropped 0.6%, abandoning gains made on optimism from a pledge by Washington and Beijing to stand by their Phase-1 trade pact.

Oil & gas companies and miners were among the top decliners by the closing bell.

British retailers have cut the most jobs since the depths of the financial crisis and expect the pace of losses to accelerate, the Confederation of British Industry said.

Sterling gained despite the monthly retail sales balance unexpectedly falling to -6 in August from July's 15-month high of +4.

The FTSE 100 is still on course for its best month since April 2018 even as concerns linger about a choppy economic recovery after a record contraction in the second quarter.

Investors are awaiting U.S. Federal Reserve Chair Jerome Powell's address at the Kansas City Fed's annual conference on Thursday for any hints as to the central bank's efforts to revamp its approach to monetary policy.

"The fact the strong start to the trading session couldn't be sustained points to an absence of conviction on traders' part. It feels like many market participants are sitting on their hands ahead of the Jackson Hole Symposium," said David Madden, market analyst at CMC Markets.

AstraZeneca Plc rose 0.1% after launching a trial for an antibody-based treatment for COVID-19.

Aveva Group rose 7.3% as it said it would buy OSIsoft, a privately held maker of industrial software used to manage plants and factories, for an enterprise value of $5 billion.

Retailer DFS Furniture Plc jumped 10.7% after saying its performance over the last six weeks was significantly above its initial expectations. (Reporting by Sagarika Jaisinghani and Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu and Bernadette Baum)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.01% 8384 Delayed Quote.14.46%
AVEVA GROUP PLC -0.58% 3583 Delayed Quote.12.55%
CMC MARKETS PLC 1.12% 453 Delayed Quote.14.58%
DFS FURNITURE PLC -3.40% 284.5 Delayed Quote.33.86%
FTSE 100 -1.90% 7017.47 Delayed Quote.10.73%
FTSE MID 250 INDEX -0.94% 22324.19 Delayed Quote.9.99%
LONDON BRENT OIL 0.80% 73.48 Delayed Quote.42.82%
MSCI UNITED KINGDOM (STRD) -1.51% 1168.561 Real-time Quote.15.08%
S&P UNITED KINGDOM (PDS) -1.95% 1397.67 Delayed Quote.11.31%
WTI 1.12% 71.64 Delayed Quote.48.31%
All news about ASTRAZENECA PLC
12:58pOntario still offering option of AstraZeneca as second shot after new NACI gu..
12:12pEurostoxx 50 : European shares deepen losses after hawkish Fed comments
11:25aTHE LATEST : Brazil to hit 500K deaths, 2nd highest globally
11:18aASTRAZENECA  : Ordered by Brussels Court to Deliver 80.2 Million COVID-19 Jabs t..
10:40aASTRAZENECA  : claims victory over EU in vaccine deliveries case
10:30aASTRAZENECA  : EU both claim a win in vaccine delivery tussle
09:50aASTRAZENECA  : Welcomes Belgian Court Ruling on COVID-19 Vaccine Supply to EU
09:31aASTRAZENECA  : Court orders AstraZeneca to deliver 50 million doses to EU by Sep..
09:06aASTRAZENECA  : EU loses bid for speedier AstraZeneca vaccine deliveries
08:24aASTRAZENECA  : Vaccine-maker AstraZeneca claims victory in court tussle with EU ..
More news
Financials (USD)
Sales 2021 30 988 M - -
Net income 2021 4 559 M - -
Net Debt 2021 10 731 M - -
P/E ratio 2021 36,8x
Yield 2021 2,44%
Capitalization 153 B 152 B -
EV / Sales 2021 5,30x
EV / Sales 2022 4,57x
Nbr of Employees 76 100
Free-Float 95,7%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 133,03 $
Last Close Price 116,84 $
Spread / Highest target 46,3%
Spread / Average Target 13,9%
Spread / Lowest Target -17,6%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC14.46%153 347
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939